EDARBI 40 MG TABLET

Azilsartan kamedoxomil
$8.2877per EA

Strength

40 mg/1

NDC

60631004030

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

AZILSARTAN KAMEDOXOMIL

Approval Type

New Drug (NDA)

FDA Application

NDA200796

On Market Since

2/1/2013

Pharmacological Classes

Angiotensin 2 Receptor Blocker
Angiotensin 2 Type 1 Receptor Antagonists
Decreased Blood Pressure

Price History

1W

0.0%

1M

-0.1%

3M

-0.0%

6M

-0.1%

1Y

-0.0%

3Y

+20.1%

5Y

+28.2%

All

+106.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.